CD269 Rabbit Polyclonal Antibody
To Order Contact us: [email protected]
CD269 Polyclonal Antibody |
|||
| ABP57376-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of CD269 from Human. This CD269 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD269 |
|||
CD269 Polyclonal Antibody |
|||
| ES8369-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against CD269 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
CD269 Polyclonal Antibody |
|||
| ES8369-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against CD269 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
Anti-CD269 antibody |
|||
| STJ97640 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to CD269. |
|||
BCMA Antibody / CD269 / TNFRSF17 |
|||
| RQ4272 | NSJ Bioreagents | 100 ug | EUR 419 |
BCMA Antibody / CD269 / TNFRSF17 |
|||
| RQ4364 | NSJ Bioreagents | 100 ug | EUR 419 |
BCMA Antibody / CD269 / TNFRSF17 |
|||
| RQ4365 | NSJ Bioreagents | 100 ug | EUR 419 |
BCMA Antibody / Cd269 / Tnfrsf17 |
|||
| RQ5844 | NSJ Bioreagents | 100 ug | EUR 419 |
BCMA Antibody / CD269 / TNFRSF17 |
|||
| V3814-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE). |
|||
BCMA Antibody / CD269 / TNFRSF17 |
|||
| V3814-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE). |
|||
CD269 Blocking Peptide |
|||
| 20-abx161058 | Abbexa |
|
|
Recombinant Human TNFRSF17/BCMA/CD269 Protein |
|||
| RP00155 | Abclonal | 5 μg | EUR 163.2 |
Tumor Necrosis Factor Receptor Superfamily Member 17 (CD269) Antibody |
|||
| 20-abx121058 | Abbexa |
|
|
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC942366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC942366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCA2366-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), APC conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC552366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC552366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC612366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC612366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCP2366-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCR2366-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC402366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC402366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC432366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC432366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC052366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC052366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC812366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC812366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC802366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC802366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCH2366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCH2366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNUB2366-100 | Biotium | 100uL | EUR 316.8 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Concentration: 0.2mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNUB2366-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), 1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNUB2366-500 | Biotium | 500uL | EUR 615.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Concentration: 0.2mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC042366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC042366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC682366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC682366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC702366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC702366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCAP2366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCAP2366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC882366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC882366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC472366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNC472366-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
| BNCB2366-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Biotin conjugate, Concentration: 0.1mg/mL |
|||